UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. Study Researching Head and Neck Cancer
    Ahmad Wehbe
  2. Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia
    Ayman El-Sheikh
  3. Factors Contributing to Low Screening Rates among Persons at Increased Risk for Colorectal Cancer
    Anne Ersig
  4. Study for Safety of the Drug Ruxolitnib
    Thomas Carter
  5. Effects of Vitamin D Replacement on Tumor Response and Survival Parameters
    Brian Link
  6. A Randomized, Multicenter, Open-Label Phase III Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine versus Trastuzumab as Adjuvant Therapy for Patients with HER2-Positive Primary Breast…
    Alexandra Thomas
  7. Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) with Commercially Supplied Sunitinib in Patients with Previously Untreated Locally Advanced or Metastatic Renal Cell Carc…
    Daniel Vaena
  8. A Randomized Phase III Study of Standard Cytarabine plus Daunorubicin (7+3) Therapy or Idarubicin with High Dose Cytarabine (IA) versus IA with Vorinostat (IA+V) in Younger Patients with Previously Un…
    Thomas Carter
  9. A randomized, double-blind, placebo-controlled, phase 3 study of brentuximab vedotin and CHP (A+CHP) versus CHOP in the frontline treatment of patient with CD30-positive mature T-cell lymphomas: the A…
    Brian Link
  10. Inotuzumab Ozogamicin in Adult Patients with Relapsed or Reractory ALL
    Thomas Carter
  11. A Phase II Study of Neoadjuvant Letrozole for Post-Menopausal Women with Estrogen Receptor Positive Ductal Carcinoma In Situ
    Alexandra Thomas
  12. A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed At Time of Radial Cystectomy For Muscle Invasive Urothelial Cancer
    Daniel Vaena
  13. Well Woman Tissue Repository
    Donna Santillan
  14. Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I
    Joseph Cullen MD
  15. An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
    Daniel Vaena
  16. The Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE Study)
    William Sivitz
  17. A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Ca…
    Daniel Vaena
  18. A Randomized, Phase III Study of Standard Dosing versus Longer Dosing Interval of Zoledronic Acid in Metastatic Cancer (VAMC)
    Daniel Vaena
  19. ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease Prostate Cancer (VAMC)
    Daniel Vaena
  20. Killer Immunoglobulin-like Receptor (KIR) Incompatible Unrelated Donor Hematopoietic Stem Cell Transplantation (SCT) for AML with Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory and Relapsed Acute…
    Ayman El-Sheikh

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.